Erste Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
76,950
+16,500
| +27% | +$547K | 0.02% | 364 |
|
|
2025
Q1 | $2.61M | Hold |
60,450
| – | – | 0.03% | 282 |
|
|
2024
Q4 | $2.86M | Hold |
60,450
| – | – | 0.04% | 284 |
|
|
2024
Q3 | $3.16M | Hold |
60,450
| – | – | 0.04% | 276 |
|
|
2024
Q2 | $3.25M | Hold |
60,450
| – | – | 0.04% | 267 |
|
|
2024
Q1 | $4.32M | Buy |
60,450
+23,000
| +61% | +$1.64M | 0.06% | 244 |
|
|
2023
Q4 | $3.12M | Buy |
37,450
+19,000
| +103% | +$1.58M | 0.05% | 260 |
|
|
2023
Q3 | $568K | Hold |
18,450
| – | – | 0.01% | 394 |
|
|
2023
Q2 | $604K | Hold |
18,450
| – | – | 0.01% | 401 |
|
|
2023
Q1 | $631K | Hold |
18,450
| – | – | 0.01% | 406 |
|
|
2022
Q4 | $843K | Hold |
18,450
| – | – | 0.02% | 375 |
|
|
2022
Q3 | $903K | Hold |
18,450
| – | – | 0.02% | 366 |
|
|
2022
Q2 | $899K | Hold |
18,450
| – | – | 0.02% | 370 |
|
|
2022
Q1 | $674K | Sell |
18,450
-4,150
| -18% | -$152K | 0.01% | 405 |
|
|
2021
Q4 | $1.05M | Buy |
+22,600
| New | +$1.05M | 0.02% | 353 |
|